nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexylcaine—SCN10A—peripheral nervous system—Parkinson's disease	0.0605	0.0879	CbGeAlD
Hexylcaine—SCN10A—nerve—Parkinson's disease	0.0471	0.0685	CbGeAlD
Hexylcaine—SCN1A—hindbrain—Parkinson's disease	0.0399	0.058	CbGeAlD
Hexylcaine—SCN2A—hindbrain—Parkinson's disease	0.0366	0.0532	CbGeAlD
Hexylcaine—SCN1A—brainstem—Parkinson's disease	0.0229	0.0332	CbGeAlD
Hexylcaine—SCN1A—forebrain—Parkinson's disease	0.0221	0.0321	CbGeAlD
Hexylcaine—SCN2A—brainstem—Parkinson's disease	0.021	0.0305	CbGeAlD
Hexylcaine—SCN2A—forebrain—Parkinson's disease	0.0202	0.0295	CbGeAlD
Hexylcaine—SCN10A—forebrain—Parkinson's disease	0.0195	0.0284	CbGeAlD
Hexylcaine—SCN3A—forebrain—Parkinson's disease	0.0178	0.0259	CbGeAlD
Hexylcaine—SCN1A—medulla oblongata—Parkinson's disease	0.0159	0.0232	CbGeAlD
Hexylcaine—SCN5A—cardiovascular system—Parkinson's disease	0.015	0.0218	CbGeAlD
Hexylcaine—SCN2A—medulla oblongata—Parkinson's disease	0.0146	0.0213	CbGeAlD
Hexylcaine—SCN1A—midbrain—Parkinson's disease	0.0146	0.0212	CbGeAlD
Hexylcaine—SCN1A—spinal cord—Parkinson's disease	0.0142	0.0207	CbGeAlD
Hexylcaine—SCN2A—midbrain—Parkinson's disease	0.0134	0.0194	CbGeAlD
Hexylcaine—SCN2A—spinal cord—Parkinson's disease	0.013	0.019	CbGeAlD
Hexylcaine—SCN3A—medulla oblongata—Parkinson's disease	0.0129	0.0187	CbGeAlD
Hexylcaine—SCN1A—head—Parkinson's disease	0.0126	0.0184	CbGeAlD
Hexylcaine—SCN10A—spinal cord—Parkinson's disease	0.0126	0.0183	CbGeAlD
Hexylcaine—Diethylpropion—SLC6A3—Parkinson's disease	0.012	0.19	CrCbGaD
Hexylcaine—SCN1A—nervous system—Parkinson's disease	0.012	0.0174	CbGeAlD
Hexylcaine—SCN3A—midbrain—Parkinson's disease	0.0118	0.0171	CbGeAlD
Hexylcaine—SCN2A—head—Parkinson's disease	0.0116	0.0169	CbGeAlD
Hexylcaine—SCN1A—central nervous system—Parkinson's disease	0.0115	0.0168	CbGeAlD
Hexylcaine—SCN3A—spinal cord—Parkinson's disease	0.0115	0.0167	CbGeAlD
Hexylcaine—SCN1A—cerebellum—Parkinson's disease	0.0113	0.0164	CbGeAlD
Hexylcaine—SCN10A—head—Parkinson's disease	0.0112	0.0163	CbGeAlD
Hexylcaine—Methylphenidate—SLC6A3—Parkinson's disease	0.011	0.175	CrCbGaD
Hexylcaine—Dexmethylphenidate—SLC6A3—Parkinson's disease	0.011	0.175	CrCbGaD
Hexylcaine—SCN2A—nervous system—Parkinson's disease	0.011	0.016	CbGeAlD
Hexylcaine—SCN10A—nervous system—Parkinson's disease	0.0106	0.0154	CbGeAlD
Hexylcaine—SCN2A—central nervous system—Parkinson's disease	0.0106	0.0154	CbGeAlD
Hexylcaine—SCN2A—cerebellum—Parkinson's disease	0.0103	0.015	CbGeAlD
Hexylcaine—SCN10A—central nervous system—Parkinson's disease	0.0102	0.0148	CbGeAlD
Hexylcaine—SCN3A—head—Parkinson's disease	0.0102	0.0148	CbGeAlD
Hexylcaine—SCN5A—head—Parkinson's disease	0.0102	0.0148	CbGeAlD
Hexylcaine—SCN3A—nervous system—Parkinson's disease	0.00966	0.0141	CbGeAlD
Hexylcaine—SCN5A—nervous system—Parkinson's disease	0.00963	0.014	CbGeAlD
Hexylcaine—SCN3A—central nervous system—Parkinson's disease	0.0093	0.0135	CbGeAlD
Hexylcaine—SCN5A—central nervous system—Parkinson's disease	0.00927	0.0135	CbGeAlD
Hexylcaine—SCN1A—brain—Parkinson's disease	0.00915	0.0133	CbGeAlD
Hexylcaine—SCN3A—cerebellum—Parkinson's disease	0.00909	0.0132	CbGeAlD
Hexylcaine—SCN3A—L1CAM interactions—DLG1—Parkinson's disease	0.00899	0.036	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—DLG1—Parkinson's disease	0.00864	0.0346	CbGpPWpGaD
Hexylcaine—SCN2A—brain—Parkinson's disease	0.0084	0.0122	CbGeAlD
Hexylcaine—Cocaine—SLC6A3—Parkinson's disease	0.00836	0.133	CrCbGaD
Hexylcaine—SCN10A—L1CAM interactions—DLG1—Parkinson's disease	0.00833	0.0334	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—DLG1—Parkinson's disease	0.00833	0.0334	CbGpPWpGaD
Hexylcaine—SCN10A—brain—Parkinson's disease	0.0081	0.0118	CbGeAlD
Hexylcaine—SCN3A—brain—Parkinson's disease	0.00738	0.0107	CbGeAlD
Hexylcaine—SCN5A—brain—Parkinson's disease	0.00736	0.0107	CbGeAlD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00636	0.0255	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—DLG1—Parkinson's disease	0.00586	0.0235	CbGpPWpGaD
Hexylcaine—Methylphenidate—CYP2D6—Parkinson's disease	0.0058	0.092	CrCbGaD
Hexylcaine—Dexmethylphenidate—CYP2D6—Parkinson's disease	0.0058	0.092	CrCbGaD
Hexylcaine—SCN3A—Axon guidance—NRTN—Parkinson's disease	0.00544	0.0218	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—NRTN—Parkinson's disease	0.00523	0.021	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—NRTN—Parkinson's disease	0.00504	0.0202	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—NRTN—Parkinson's disease	0.00504	0.0202	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00482	0.0193	CbGpPWpGaD
Hexylcaine—Oxybutynin—CYP2D6—Parkinson's disease	0.00464	0.0735	CrCbGaD
Hexylcaine—Cocaine—CYP2D6—Parkinson's disease	0.00439	0.0697	CrCbGaD
Hexylcaine—SCN3A—L1CAM interactions—HSPA8—Parkinson's disease	0.0042	0.0169	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—HSPA8—Parkinson's disease	0.00404	0.0162	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—DLG4—Parkinson's disease	0.00394	0.0158	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—HSPA8—Parkinson's disease	0.00389	0.0156	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—HSPA8—Parkinson's disease	0.00389	0.0156	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—NRTN—Parkinson's disease	0.00388	0.0156	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—DLG4—Parkinson's disease	0.00379	0.0152	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—NRTN—Parkinson's disease	0.00373	0.015	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—DLG4—Parkinson's disease	0.00365	0.0146	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—DLG4—Parkinson's disease	0.00365	0.0146	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—NRTN—Parkinson's disease	0.0036	0.0144	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—NRTN—Parkinson's disease	0.0036	0.0144	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—NRTN—Parkinson's disease	0.00355	0.0142	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—DLG1—Parkinson's disease	0.0034	0.0136	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—IGF2—Parkinson's disease	0.00328	0.0131	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—DLG1—Parkinson's disease	0.00326	0.0131	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—DLG1—Parkinson's disease	0.00315	0.0126	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—DLG1—Parkinson's disease	0.00315	0.0126	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00301	0.0121	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—HSPA8—Parkinson's disease	0.00274	0.011	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—GDNF—Parkinson's disease	0.00266	0.0107	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—DLG4—Parkinson's disease	0.00257	0.0103	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—GDNF—Parkinson's disease	0.00255	0.0102	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—NRTN—Parkinson's disease	0.00253	0.0101	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—GDNF—Parkinson's disease	0.00246	0.00987	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—GDNF—Parkinson's disease	0.00246	0.00987	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—DLG1—Parkinson's disease	0.00242	0.00972	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—DLG1—Parkinson's disease	0.00233	0.00934	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—DLG1—Parkinson's disease	0.00225	0.009	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—DLG1—Parkinson's disease	0.00225	0.009	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—DLG1—Parkinson's disease	0.00221	0.00887	CbGpPWpGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—INS—Parkinson's disease	0.00218	0.00872	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00202	0.00812	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00195	0.00781	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00192	0.0077	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—GDNF—Parkinson's disease	0.0019	0.00761	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—GDNF—Parkinson's disease	0.00182	0.00731	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—GDNF—Parkinson's disease	0.00176	0.00705	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—GDNF—Parkinson's disease	0.00176	0.00705	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—GDNF—Parkinson's disease	0.00173	0.00694	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00168	0.00673	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—HSPA8—Parkinson's disease	0.00159	0.00637	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—DLG1—Parkinson's disease	0.00158	0.00633	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—HSPA8—Parkinson's disease	0.00153	0.00612	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—DLG4—Parkinson's disease	0.00149	0.00598	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—HSPA8—Parkinson's disease	0.00147	0.0059	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—HSPA8—Parkinson's disease	0.00147	0.0059	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—GRIN2B—Parkinson's disease	0.00146	0.00584	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—DLG4—Parkinson's disease	0.00143	0.00574	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00142	0.00568	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—GRIN2B—Parkinson's disease	0.0014	0.00561	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—DLG4—Parkinson's disease	0.00138	0.00554	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—DLG4—Parkinson's disease	0.00138	0.00554	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00137	0.00548	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—GRIN2B—Parkinson's disease	0.00135	0.00541	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—GRIN2B—Parkinson's disease	0.00135	0.00541	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—GDNF—Parkinson's disease	0.00124	0.00495	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00121	0.00486	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—ABL1—Parkinson's disease	0.00119	0.00476	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00115	0.00463	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—ABL1—Parkinson's disease	0.00114	0.00457	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—HSPA8—Parkinson's disease	0.00113	0.00454	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—ABL1—Parkinson's disease	0.0011	0.00441	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—ABL1—Parkinson's disease	0.0011	0.00441	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—HSPA8—Parkinson's disease	0.00109	0.00437	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—DLG4—Parkinson's disease	0.00106	0.00426	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—HSPA8—Parkinson's disease	0.00105	0.00421	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—HSPA8—Parkinson's disease	0.00105	0.00421	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—GRIN2B—Parkinson's disease	0.00104	0.00417	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—HSPA8—Parkinson's disease	0.00103	0.00415	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—DLG4—Parkinson's disease	0.00102	0.0041	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—GRIN2B—Parkinson's disease	0.000999	0.004	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—DLG4—Parkinson's disease	0.000985	0.00395	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—DLG4—Parkinson's disease	0.000985	0.00395	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—DLG4—Parkinson's disease	0.000971	0.00389	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—GRIN2B—Parkinson's disease	0.000963	0.00386	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—GRIN2B—Parkinson's disease	0.000963	0.00386	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	0.000949	0.0038	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—ABL1—Parkinson's disease	0.000847	0.0034	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—ABL1—Parkinson's disease	0.000814	0.00326	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—ABL1—Parkinson's disease	0.000785	0.00315	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—ABL1—Parkinson's disease	0.000785	0.00315	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—ABL1—Parkinson's disease	0.000773	0.0031	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	0.000738	0.00296	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—DLG4—Parkinson's disease	0.000693	0.00278	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000684	0.00274	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000683	0.00274	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	0.000677	0.00271	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—INS—Parkinson's disease	0.00056	0.00225	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—ABL1—Parkinson's disease	0.000552	0.00221	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—INS—Parkinson's disease	0.000538	0.00216	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—INS—Parkinson's disease	0.000519	0.00208	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—INS—Parkinson's disease	0.000519	0.00208	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000497	0.00199	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000401	0.00161	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—INS—Parkinson's disease	0.000365	0.00146	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—IL6—Parkinson's disease	0.000343	0.00137	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—IL6—Parkinson's disease	0.000329	0.00132	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—IL6—Parkinson's disease	0.000318	0.00127	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—IL6—Parkinson's disease	0.000318	0.00127	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—TNF—Parkinson's disease	0.000303	0.00122	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—TNF—Parkinson's disease	0.000291	0.00117	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—TNF—Parkinson's disease	0.000281	0.00113	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—TNF—Parkinson's disease	0.000281	0.00113	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—IL6—Parkinson's disease	0.000245	0.000981	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—IL6—Parkinson's disease	0.000235	0.000943	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—IL6—Parkinson's disease	0.000227	0.000909	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—IL6—Parkinson's disease	0.000227	0.000909	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—IL6—Parkinson's disease	0.000223	0.000895	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—TNF—Parkinson's disease	0.000197	0.000792	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—IL6—Parkinson's disease	0.000159	0.000639	CbGpPWpGaD
